T2 Biosystems Inc EV/Sales
Was ist das EV/Sales von T2 Biosystems Inc?
EV/Sales von T2 Biosystems Inc ist 10.64
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc
Was macht T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Unternehmen mit ev/sales ähnlich T2 Biosystems Inc
- Poly Ppty Dvlp Co Ltd hat EV/Sales von 10.62
- Inventiva SA hat EV/Sales von 10.62
- IM+ Capitals hat EV/Sales von 10.63
- Telesites SAB de CV hat EV/Sales von 10.63
- RioCan Real Estate Investment Trust hat EV/Sales von 10.63
- Network-1 Technologies Inc hat EV/Sales von 10.64
- T2 Biosystems Inc hat EV/Sales von 10.64
- Lattice Semiconductor hat EV/Sales von 10.65
- Cardax hat EV/Sales von 10.66
- LXI REIT Plc hat EV/Sales von 10.66
- Evotec SE hat EV/Sales von 10.67
- Eve & Co hat EV/Sales von 10.67
- FSA hat EV/Sales von 10.68